SCHEMBL6986218

SCHEMBL6986218

CC(CCNC(=O)c1ccc(OC(F)(F)F)cc1)CC(=O)NC1(C)C(=O)COC1C

nearest known ligand 0.40

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 13/20 0.40
MCHR1 Q99705 1/20 0.38
EPHX2 P34913 2/20 0.38
NR1H4 Q96RI1 1/20 0.38
DHODH Q02127 1/20 0.38
IDH1 O75874 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6985955 0.89 NAMPT (0.37) MCHR1EPHX2DHODH
SCHEMBL6987802 0.89 KMT2A (0.41) EPHX2
SCHEMBL6989326 0.87 RAB9A (0.38) TRPV1NR1H4
SCHEMBL6985875 0.86 LMNA (0.40) MCHR1
SCHEMBL6985259 0.84 HDAC1 (0.40)
SCHEMBL6987790 0.83 TAS1R3 (0.38)
SCHEMBL6986287 0.80 CHRM4 (0.39)
SCHEMBL6990430 0.78 GCGR (0.41)
SCHEMBL6749621 0.78 CTSK (0.45)
SCHEMBL6981853 0.76 TRPV1 (0.42) TRPV1EPHX2NR1H4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1362042-A1 CYCLIC 2-CARBONYLAMINOKETONES AS INHIBITORS OF CRUZIPAIN AND OTHER CYSTEINE PROTEASES Amura Therapeutics Limited (GB) 2003-11-19 EP disclosed
WO-2002057249-A1 CYCLIC 2-CARBONYLAMINOKETONES AS INHIBITORS OF CRUZIPAIN AND OTHER CYSTEINE PROTEASES AMURA THERAPEUTICS LIMITED (GB) 2002-07-25 WO disclosed